Rhinitis medicamentosa is due to-
The core concept here is that prolonged use of topical decongestants leads to rebound congestion. The correct answer should relate to the mechanism involving vasoconstriction and subsequent rebound vasodilation. The main decongestants involved are alpha-adrenergic agonists like oxymetazoline.
Now, looking at the options (though they aren't provided here), common distractors might include things like antihistamines, corticosteroids, or other causes like infections. I need to explain why those are incorrect. For example, antihistamines are used for allergic rhinitis but don't cause rhinitis medicamentosa. Corticosteroids are anti-inflammatory and don't lead to rebound congestion.
The clinical pearl here is to remember that overusing nasal sprays can lead to chronic inflammation and dependency. A high-yield fact is that patients should be advised not to use decongestant nasal sprays for more than 3-5 days to avoid this condition.
I need to structure the explanation with the required sections. Make sure to mention the alpha-adrenergic receptors and the rebound effect. Also, clarify why other options are wrong by addressing their mechanisms. Keep the language precise but clear for postgraduate students.
**Core Concept**
Rhinitis medicamentosa is a **rebound nasal congestion** caused by excessive use of **topical alpha-adrenergic agonist nasal decongestants** (e.g., oxymetazoline). Chronic vasoconstriction leads to **rebound vasodilation** and **inflammation** of nasal mucosa.
**Why the Correct Answer is Right**
Topical decongestants initially cause vasoconstriction of nasal blood vessels, reducing swelling. Prolonged use downregulates alpha-1 adrenergic receptors, leading to **paradoxical vasodilation** and **chronic inflammation**. This creates a cycle of dependency, where patients use sprays more frequently to relieve worsening congestion.
**Why Each Wrong Option is Incorrect**
**Option A:** Antihistamines cause dryness but not rebound congestion.
**Option B:** Corticosteroids reduce inflammation and are not implicated in this condition.
**Option C:** Allergic rhinitis involves IgE-mediated mast cell degranulation, unrelated to decongestant overuse.
**Clinical Pearl / High-Yield Fact**
Avoid using topical decongestant nasal sprays for **>3β5 days** to prevent rhinitis medicamentosa. Patients often deny overuse (βI only use it occasionally!β), so ask about frequency explicitly.
**Correct Answer: C. Topical decongestant overuse**